Summary
A modular method for pursuing structure-based inhibitor design in the framework of a design cycle is presented. The approach entails four stages: (1) a design pathway is defined in the three-dimensional structure of a target protein; (2) this pathway is divided into subregions; (3) complementary building blocks, also called fragments, are designed in each subregion; complementarity is defined in terms of shape, hydrophobicity, hydrogen bond properties and electrostatics; and (4) fragments from different subregions are linked into potential lead compounds. Stages (3) and (4) are qualitatively guided by force-field calculations. In addition, the designed fragments serve as entries for retrieving existing compounds from chemical databases. This linked-fragment approach has been applied in the design of potentially selective inhibitors of triosephosphate isomerase from Trypanosoma brucei, the causative agent of sleeping sickness.
Similar content being viewed by others
References
Maugh, T.M., Science, 196 (1977) 413.
Falco, E.A., Goodwin, L.G., Hitchings, G.H., Rollo, I.M. and Russell, P.B., Brit. J. Pharmacol., 6 (1951) 185.
Hol, W.G.J., Angew. Chem. Int. Ed. Engl., 25 (1986) 767.
Erickson, J., Neidhart, D.J., VanDrie, J., Kempf, D.J., Wang, X.C., Norbeck, D.W., Plattner, J.J., Rittenhouse, J.W., Turon, M., Wideburg, M., Kohlbrenner, W.E., Simmer, R., Helfrich, R., Paul, D.A. and Knigge, M., Science, 249 (1990) 527.
Lewis, R.A. and Dean, P.M., Proc. R. Soc. Lond., B, 236 (1989) 125.
Lewis, R.A., J. Comput.-Aided Mol. Design, 4 (1990) 205.
Goodford, P.J., J. Med. Chem., 28 (1985) 849.
Boobbyer, D.N.A., Goodford, P.J., McWhinnie, P.M. and Wade, R.C., J. Med. Chem., 32 (1989) 1083.
Lesk, A.M., Acta Crystallogr., A 42 (1986) 83.
Allen, F.H., Bellard, S., Brice, M.D., Cartwright, B.A., Doubleday, A., Higgs, H., Hummelink, T., Hummelink-Peters, B.G., Kennard, O., Motherwell, W.D.S., Rodgers, J.R. and Watson, D.G., Acta Crystallogr., B, 35 (1979) 2331.
Rusinko, III, A., Sheridan, R.P., Nilakantan, R., Haraki, K.S., Bauman, N. and Venkataraghavan, R., J. Chem. Inf. Comput. Sci., 29 (1989) 251.
DesJarlais, R.L., Sheridan, R.P., Seibel, G.L., Dixon, J.S., Kuntz, I.D. and Venkataraghavan, R., J. Med. Chem., 31 (1988) 722.
Sheridan, R.P., Nilakantan, R., Rusinko, III, A., Bauman, N., Haraki, K.S. and Venkataraghavan, R., J. Chem. Inf. Comput. Sci., 29 (1989) 255.
Sheridan, R.P., Rusinko, III, A., Nilakantan, R. and Venkataraghavan, R., Proc. Natl. Acad. Sci. U.S.A., 86 (1989) 8165.
VanDrie, J.H., Weiniger, D. and Martin, Y.C., J. Comput.-Aided Mol. Design, 3 (1989) 225.
DesJarlais, R.L., Seibel, G.L., Kuntz, I.D., Furth, P.S., Alvarez, J.C., Oritz de Montellano, P.R., De, Camp, D.L., Babe, L.M. and Craik, C.S., Proc. Natl. Acad. Sci. U.S.A., 87 (1990) 6644.
Hol, W.G.J., In Blöcker, H., Collins, J., Schmid, R.D. and Schomburg, D. (Eds.) Advances in Protein Design, GBF Monographs, VCH Verlaggesellschaft, Weinheim, 1989, pp. 27–34.
WHO, TDR, Seventh Program Report, Tropical Disease Research, WHO, Geneva, 1985.
Haller, L., Adams, J.H., Merouse, F. and Dago, A., Am. J. Trop. Med. Hyg., 35 (1986) 94.
Tropical Drug Research News, 34 (1990) 1.
Bellofatto, V., Fairlamb, A., Henderson, G.B. and Cross, G.A.M., Mol. Biochem. Parasitol., 25 (1987) 227.
Tropical Drug Research News, 35 (1991) 7.
Hol, W.G.J., Wierenga, R.K., Groendijk, H., Read, R.J., Thunnissen, A.M.W.H., Noble, M.E.M., Kalk, K.H., Vellieux, F.M.D., Opperdoes, F.R. and Michels, P.A.M., In Roberts, S.M. (Ed.), Molecular Recognition: Chemical and Biochemical Problems, The Royal Society of Chemistry, 1989, pp. 84–93.
Opperdoes, F.R., Annu. Rev. Microbiol., 41 (1987) 127.
Misset, O., Bos, O.J.M. and Opperdoes, F.R., Eur. J. Biochem., 157 (1986) 441.
Opperdoes, F.R., Wierenga, R.K., Noble, M.E.M., Hol, W.G.J., Willson, M., Kuntz, D.A., Callens, M. and Perié, J., In Parasites: Molecular Biology, Drug and Vaccine Design, Wiley-Liss, Inc., 1990, pp. 233–246.
Wierenga, R.K., Kalk, K.H. and Hol, W.G.J., J. Mol. Biol., 198 (1987) 109.
Wierenga, R.K., Noble, M.E.M., Vriend, G., Nauche, S. and Hol, W.G.J., J. Mol. Biol., 220 (1991) 995.
Lambeir, A.M., Opperdoes, F.R. and Wierenga, R.K., Eur. J. Biochem., 168 (1987) 69.
Pompliano, D.L., Peyman, A. and Knowles, J.R., Biochemistry, 29 (1990) 3186.
Verlinde, C.L.M.J., Noble, M.E.M., Kalk, K.H., Groendijk, H., Wierenga, R.K. and Hol, W.G.J., Eur. J. Biochem., 198 (1991) 53.
Noble, M.E.M., Wierenga, R.K., Lambeir, A.M., Opperdoes, F.R., Thunnissen, A.M.W.H., Kalk, K.H., Groendijk, H. and Hol, W.G.J., Proteins, 10 (1991) 50.
Noble, M.E.M., Verlinde, C.L.M.J., Groendijk, H., Kalk, K.H., Wierenga, R.K. and Hol, W.G.J., J. Med. Chem., 34 (1991) 2709.
BIOGRAF 2.10: Molecular Simulations, Inc., 796 North Pastoria Ave, Sunnyvale, CA 94086, U.S.A.
Richards, F.M., Annu. Rev. Biophys. Bioeng., 6 (1977) 151.
Van, Gunsteren, W.F. and Berendsen, H.J.C., Angew. Chem. Int. Ed. Engl., 29 (1990) 992.
Müller, K., Ammann, H.J., Doran, D.M., Gerber, P.M., Gubernator, K. and Schrepfer, G., In van der, Goot, H., Domány, G., Pallos, L. and Timmerman, H. (Eds.) Trends in Medicinal Chemistry '88, Elsevier Science Publishers B.V., Amsterdam, 1989, pp. 1–12.
OSAC-Organic Structures Accessed by Computers: ORAC, Ltd., Leeds, UK, 1990.
Banner, B.W., Bloomer, A.C., Petsko, G.A., Philips, D.C., Pogson, C.I., Wilson, I.A., Corran, P.H., Furth, A.J., Milman, J.D., Offord, R.E., Priddle, J.D. and Waley, S.G., Nature, 255 (1975) 609.
Straus, D. and Gilbert, W., Proc. Natl. Acad. Sci. U.S.A., 82 (1985) 2014.
Maquat, L.E., Chilcote, R. and Ryan, P.M., J. Biol. Chem., 260 (1985) 3748.
Swinkels, B.W., Gibson, W.C., Osinga, K.A., Kramer, R., Veeneman, G.H., van, Boom, J.H. and Borst, P., EMBO J., 5 (1986) 1291.
Waley, S.G., Biochem. J., 135 (1973) 165.
Cherbuliez, E. and Rabinowitz, J., Helv. Chim. Acta, 39 (1956) 1455.
Krueger, F. and Schmidt, G., Ger. Offen. DE 2453037 (1976).
Feuer, L., Furka, A., Hrcsel, J., Horvath, A. and Sebestyen, F., U.S. 4218404 (1980).
Moschidis, M.C. and Demopoulos, C.A., J. Chromatogr., 294 (1984) 403.
Sukhanov, V.A., Sergovskaya, N.L., Shvets, V.I. and Evstigneeva, R.P., Zh. Obshch. Khim., 47, (1977) 2130.
Laboratories le Brun, Fr. 1.072.327 (1954).
Sharp, K.A., Nicholls, A., Fine, R.F. and Honig, B., Science, 252 (1991) 106.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verlinde, C.L.M.J., Rudenko, G. & Hol, W.G.J. In search of new lead compounds for trypanosomiasis drug design: A protein structure-based linked-fragment approach. J Computer-Aided Mol Des 6, 131–147 (1992). https://doi.org/10.1007/BF00129424
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00129424